Bayesian modeling and inference for clinical trials with partial retrieved data following dropout

Stat Med. 2013 Oct 30;32(24):4180-95. doi: 10.1002/sim.5812. Epub 2013 Apr 26.


In randomized clinical trials, it is common that patients may stop taking their assigned treatments and then switch to a standard treatment (standard of care available to the patient) but not the treatments under investigation. Although the availability of limited retrieved data on patients who switch to standard treatment, called off-protocol data, could be highly valuable in assessing the associated treatment effect with the experimental therapy, it leads to a complex data structure requiring the development of models that link the information of per-protocol data with the off-protocol data. In this paper, we develop a novel Bayesian method to jointly model longitudinal treatment measurements under various dropout scenarios. Specifically, we propose a multivariate normal mixed-effects model for repeated measurements from the assigned treatments and the standard treatment, a multivariate logistic regression model for those stopping the assigned treatments, logistic regression models for those starting a standard treatment off protocol, and a conditional multivariate logistic regression model for completely withdrawing from the study. We assume that withdrawing from the study is non-ignorable, but intermittent missingness is assumed to be at random. We examine various properties of the proposed model. We develop an efficient Markov chain Monte Carlo sampling algorithm. We analyze in detail via the proposed method a real dataset from a clinical trial.

Keywords: Markov chain Monte Carlo; intermittent missingness; logistic regression model; missing at random; multivariate mixed-effects model.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Algorithms
  • Bayes Theorem*
  • Cognitive Dysfunction / drug therapy
  • Data Interpretation, Statistical*
  • Humans
  • Markov Chains
  • Models, Statistical*
  • Monte Carlo Method
  • Patient Dropouts*
  • Phenylcarbamates / therapeutic use
  • Randomized Controlled Trials as Topic / methods*
  • Rivastigmine


  • Phenylcarbamates
  • Rivastigmine